Global Liquid Biopsy MarketThe global liquid biopsy market is on a trajectory of significant expansion, with its market share estimated to generate a revenue of USD 1,538.3 million in 2023. According ...

GC Genome Corporation, a leading diagnostics company, presented new data from its AI-based liquid biopsy platform for ...

CHICAGO – With new results validating its PreveCol liquid biopsy test for colorectal cancer, Spanish diagnostic company Amadix is preparing for the US launch of its screening assay. In data presented ...

The NeXT Personal test is the first of a new class of ultra-sensitive liquid biopsy tests designed to detect the earliest traces of cancer recurrence and monitor a patient's response to therapy. The ...

One analyst said Grail, with a cash burn of $532 million in 2023, is likely to remain “a cautionary tale in diagnostics for years to come.” ...

The FDA selected the first participants in a program that top official Peter Marks once billed as an Operation Warp Speed for ...

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key ...

Since 2016, the MUHC Foundation’s Le Bal Rouge has raised over $8,750,000 million to support innovative research and ...

Researchers have developed a new blood test that could significantly improve the prognosis for many women, offering hope for more effective long-term treatments in breast cancer.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced new strategic ...

Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "United States Liquid Biopsy Market (by Circulating Biomarker, Product, Application, Cancer Types, Non-Cancer Application, End User, Clinical Application, ...